N.B. Feldman
- Biomaterials top 10%
- Advanced Cellulose Research Studies 4
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 4
-
- Berberine and alkaloids research 8
- Pharmacological Effects of Natural Compounds 3
-
- Synthesis and bioactivity of alkaloids 8
-
- Nanoparticles: synthesis and applications 7
-
- Silymarin and Mushroom Poisoning 4
-
- Surfactants and Colloidal Systems 3
- Co-authors
- С. В. ЛуценкоNurbubu T. MoldogazievaInnokenty M. MokhosoevSeverin SeТ. И. ГромовыхI. I. KrasnyukВ. С. СадыковаГ. А. Посыпанова
- Journals
- International Journal of Nanotechnology (7 papers)Tumor Biology (2 papers)FEBS Letters (1 paper)
- Partner nations
- RussiaUnited StatesCzechia
In The Last Decade
N.B. Feldman
40 papers receiving 629 citations
Peers
Comparison fields: 5 of 105
- Biomaterials 156
- Pharmaceutical Science 36
- Biological Psychiatry 13
- Biochemistry 31
- Biochemistry 33
Countries citing papers authored by N.B. Feldman
This map shows the geographic impact of N.B. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.B. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.B. Feldman more than expected).
Fields of papers citing papers by N.B. Feldman
This network shows the impact of papers produced by N.B. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.B. Feldman. The network helps show where N.B. Feldman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N.B. Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 8 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 48 | |
| 5 | 2020 | 36 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 1 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 1 | |
| 10 | 2019 | 0 | |
| 11 | 2018 | 3 | |
| 12 | 2018 | 2 | |
| 13 | 2018 | 223 | |
| 14 | 2018 | 5 | |
| 15 | 2007 | 33 | |
| 16 | 2002 | 23 | |
| 17 | 2000 | 14 | |
| 18 | 1999 | 13 | |
| 19 | 1999 | 17 | |
| 20 | [Antitumor activity of a covalent conjugate of the endiene antibiotic esperamicin A1 with human alpha-fetoprotein]. | 1999 | 7 |
About N.B. Feldman
N.B. Feldman is a scholar working on Complementary and Manual Therapy, Pharmaceutical Science, Biomaterials, Pharmacology and Biotechnology, having authored 42 papers that have together received 651 indexed citations. Recurring topics across this work include Berberine and alkaloids research (8 papers), Synthesis and bioactivity of alkaloids (8 papers), Nanoparticles: synthesis and applications (7 papers), Advanced Drug Delivery Systems (4 papers), Advanced Cellulose Research Studies (4 papers), Silymarin and Mushroom Poisoning (4 papers), Surfactants and Colloidal Systems (3 papers) and Pharmacological Effects of Natural Compounds (3 papers). The work is most often cited by research in Biomaterials (156 citations), Pharmaceutical Science (36 citations), Biological Psychiatry (13 citations), Biochemistry (31 citations) and Biochemistry (33 citations). N.B. Feldman has collaborated with scholars based in Russia, United States and Czechia. Frequent co-authors include С. В. Луценко, Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, Severin Se, Т. И. Громовых, I. I. Krasnyuk, В. С. Садыкова, Г. А. Посыпанова, М. А. Пигалева and Andrey N. Kuskov. Their work appears in journals such as International Journal of Nanotechnology, Tumor Biology, FEBS Letters, Colloid & Polymer Science and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.